Novel piperazine derivatives are provided having the formula ##STR1##

wherein R1 is cyano, nitro, trifluoromethyl or halogen, or pharmaceutically acceptable acid addition salts thereof, which are useful as 5-HT1A receptor antagonists.

 
Web www.patentalert.com

< Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

< Pyrazolotriazines as CRF antagonists

> Fatty acid analogues for the treatment of diseases caused by the pathological proliferation of smooth muscle cells

> Intermediate arylamine compounds

~ 00252